Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins.

Authors:
Chan Zhou Samuel R York Jennifer Y Chen Joshua V Pondick Daniel L Motola Raymond T Chung Alan C Mullen

Genome Med 2016 Mar 23;8(1):31. Epub 2016 Mar 23.

Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA.

Background: Hepatic fibrosis is the underlying cause of cirrhosis and liver failure in nearly every form of chronic liver disease, and hepatic stellate cells (HSCs) are the primary cell type responsible for fibrosis. Long noncoding RNAs (lncRNAs) are increasingly recognized as regulators of development and disease; however, little is known about their expression in human HSCs and their function in hepatic fibrosis.

Methods: We performed RNA sequencing and ab initio assembly of RNA transcripts to define the lncRNAs expressed in human HSC myofibroblasts. We analyzed chromatin immunoprecipitation data and expression data to identify lncRNAs that were regulated by transforming growth factor beta (TGF-β) signaling, associated with super-enhancers and restricted in expression to HSCs compared with 43 human tissues and cell types. Co-expression network analyses were performed to discover functional modules of lncRNAs, and principle component analysis and K-mean clustering were used to compare lncRNA expression in HSCs with other myofibroblast cell types.

Results: We identified over 3600 lncRNAs that are expressed in human HSC myofibroblasts. Many are regulated by TGF-β, a major fibrotic signal, and form networks with genes encoding key components of the extracellular matrix (ECM), which is the substrate of the fibrotic scar. The lncRNAs directly regulated by TGF-β signaling are also enriched at super-enhancers. More than 400 of the lncRNAs identified in HSCs are uniquely expressed in HSCs compared with 43 other human tissues and cell types and HSC myofibroblasts demonstrate different patterns of lncRNA expression compared with myofibroblasts originating from other tissues. Co-expression analyses identified a subset of lncRNAs that are tightly linked to collagen genes and numerous proteins that regulate the ECM during formation of the fibrotic scar. Finally, we identified lncRNAs that are induced during progression of human liver disease.

Conclusions: lncRNAs are likely key contributors to the formation and progression of fibrosis in human liver disease.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13073-016-0285-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804564PMC
March 2016

Publication Analysis

Top Keywords

hsc myofibroblasts
12
expressed human
12
lncrnas
10
extracellular matrix
8
tissues cell
8
human tissues
8
lncrna expression
8
compared human
8
fibrotic scar
8
liver disease
8
tgf-β signaling
8
human liver
8
cell types
8
regulated tgf-β
8
form networks
8
lncrnas expressed
8
long noncoding
8
noncoding rnas
8
stellate cells
8
human hsc
8

Keyword Occurance

Similar Publications

Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?

Authors:
Federico Lucantoni Andreu Martínez-Cerezuela Aleksandra Gruevska Ángela B Moragrega Víctor M Víctor Juan V Esplugues Ana Blas-García Nadezda Apostolova

J Pathol 2021 Apr 8. Epub 2021 Apr 8.

Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.

Liver fibrosis (LF) occurs as a result of persistent liver injury and can be defined as a pathologic, chronic, wound-healing process in which functional parenchyma is progressively replaced by fibrotic tissue. As a phenomenon involved in the majority of chronic liver diseases, and therefore prevalent, it exerts a significant impact on public health. This impact becomes even more patent given the lack of a specific pharmacological therapy, with LF only being ameliorated or prevented through the use of agents that alleviate the underlying causes. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Perivenous stellate cells are the main source of myofibroblasts and cancer-associated-fibroblasts formed after chronic liver injuries.

Authors:
Shan-Shan Wang Xinyu Thomas Tang Minghui Lin Jia Yuan Yi Jacky Peng Xiujuan Yin GuoGuo Shang Gaoxiang Ge Zhenggang Ren Bo O Zhou

Hepatology 2021 Apr 5. Epub 2021 Apr 5.

State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, CAS Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, China.

Studies of the identity and pathophysiology of fibrogenic hepatic stellate cells (HSCs) have been hampered by a lack of genetic tools that permit specific and inducible fate-mapping of these cells in vivo. Here, by single cell RNA sequencing of non-parenchymal cells from mouse liver, we identified Tcf21 as a unique marker that restricted its expression to quiescent HSCs. Tracing Tcf21 cells by Tcf21-CreER targeted ~10% of all HSCs, most of which located at periportal and pericentral zones. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Albumin inhibits the nuclear translocation of Smad3 via interleukin-1beta signaling in hepatic stellate cells.

Authors:
Ji Hoon Park Janghyun Kim So-Young Choi Boram Lee Jung-Eun Lee Heekyung Park Ji Wook Moon Sun-Hwa Park Jae Min Lee Hong Sik Lee Junseo Oh

Sci Rep 2021 Feb 4;11(1):3196. Epub 2021 Feb 4.

Department of Anatomy, Korea University College of Medicine, Seoul, 02841, Korea.

Activation of quiescent hepatic stellate cells (HSCs) to myofibroblasts plays a key role in liver fibrosis. We had previously shown that albumin and its derivative, R-III (a retinol-binding protein-albumin domain III fusion protein), inhibited HSC activation by sequestering retinoic acid (RA) and that R-III administration reduced carbon tetrachloride (CCl)-induced liver fibrosis. In this study, we aimed to elucidate the mechanism of action of albumin downstream of RA sequestration. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Induced hepatic stellate cell integrin, α8β1, enhances cellular contractility and TGFβ activity in liver fibrosis.

Authors:
Norihisa Nishimichi Kazuyuki Tsujino Keishi Kanno Kazuhiro Sentani Tsuyoshi Kobayashi Kazuaki Chayama Dean Sheppard Yasuyuki Yokosaki

J Pathol 2021 Apr 19;253(4):366-373. Epub 2021 Feb 19.

Integrin-Matrix Biomedical Science, Translational Research Center, Hiroshima University, Hiroshima, Japan.

No effective therapy exists for fatal fibrosis. New therapeutic targets are needed for hepatic fibrosis because the incidence keeps increasing. The activation and differentiation of fibroblasts into myofibroblasts that causes excessive matrix deposition is central to fibrosis. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:
Daniel Sepulveda-Crespo Salvador Resino Isidoro Martinez

Drugs 2021 Mar;81(4):419-443

Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III (Campus Majadahonda), Carretera Majadahonda-Pozuelo, Km 2.2, 28220, Majadahonda, Madrid, Spain.

Direct-acting antivirals eliminate hepatitis C virus (HCV) in more than 95% of treated individuals and may abolish liver injury, arrest fibrogenesis, and reverse fibrosis and cirrhosis. However, liver regeneration is usually a slow process that is less effective in the late stages of fibrosis. What is more, fibrogenesis may prevail in patients with advanced cirrhosis, where it can progress to liver failure and hepatocellular carcinoma. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap